SurgePays, Inc. (SURG)
(Real Time Quote from BATS)
$3.06 USD
-0.01 (-0.33%)
Updated Jul 22, 2024 11:06 AM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Brokerage Reports
0 items in cart
SurgePays, Inc. [SURG]
Reports for Purchase
Showing records 1 - 12 ( 12 total )
Company: SurgePays, Inc.
Industry: Internet - Software
Increased Optimism As Signs Emerge That The Affordable Connectivity Program Could Be Funded
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Expect Solid 1Q:24 Results With 2Q:24 Being A Reset Quarter As ACP Funding Remains Unclear
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Initiate Coverage With $4 Price Target, Moderate Risk Rating
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Initiate Coverage With $4 Price Target, Moderate Risk Rating
Provider: Sidoti CSR
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Internet - Software
Optimized Entry and Exit Levels for SURG 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: SurgePays, Inc.
Industry: Medical - Instruments
Company: SurgePays, Inc.
Industry: Medical - Instruments
SURG Q1/12 results solid; Lowering to Neutral on reaching price target
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: SurgePays, Inc.
Industry: Medical - Instruments
Company: SurgePays, Inc.
Industry: Medical - Instruments
ValuEngine Detailed Valuation Report for SURG
Provider: VALUENGINE, INC
Company: SurgePays, Inc.
Industry: Medical - Instruments
Q2/11 positive, market downturn presents short-term buying opportunity
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
Company: SurgePays, Inc.
Industry: Medical - Instruments
A FOUR STAR PATENTVEST IP VALUE COMPANY - 2011 "BEST AND BRIGHTEST" PATENTVEST REPORTS
Provider: MDB CAPITAL GROUP LLC
Company: SurgePays, Inc.
Industry: Medical - Instruments
we are initiating coverage on SURG with a BUY rating and 12-18 month price target of $6.25 per share
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: WASSERMAN R
|